Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
about
Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of PoxvirusesPhosphatidylserine receptors: enhancers of enveloped virus entry and infectionPre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccineHepatitis B virus large surface protein: function and fame.GSIV serine/threonine kinase can induce apoptotic cell death via p53 and pro-apoptotic gene Bax upregulation in fish cells.Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assayHBsAg Quantification in Clinical Practice.Autoimmunity vs. cancer: predator vs. alien?Old and new adjuvants for hepatitis B vaccines.Targeting of the hydrophobic metabolome by pathogens.Viral apoptotic mimicry.Exploiting death: apoptotic immunity in microbial pathogenesis.Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes.Effective binding of a phosphatidylserine-targeting antibody to Ebola virus infected cells and purified virionsSingapore grouper iridovirus, a large DNA virus, induces nonapoptotic cell death by a cell type dependent fashion and evokes ERK signaling.Chimeric Rabbit/Human Fab Antibodies Against the Hepatitis B e-antigen and Their Potential Applications in Assay, Characterization and Therapy.Clinical implications of the titer of serum hepatitis B surface antigen during the natural history of hepatitis B virus infection.Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection.PS, It's Complicated: The Roles of Phosphatidylserine and Phosphatidylethanolamine in the Pathogenesis of Candida albicans and Other Microbial Pathogens.
P2860
Q26797325-DB784DAC-DAE5-49CE-92B6-B83BD37DF937Q27015034-2DCFCFFC-2BB8-4662-B01C-A21B3D2DCAE0Q33359620-2252A8B3-A09A-4342-9AA3-E0DE79E99FAFQ35055364-39603A6F-3CDC-4DE1-BBFD-3AD204E19F51Q35911401-651F6A79-EC8F-45F4-8BD8-EDFCC9529A2EQ37135543-BFCC256A-6588-4780-BC6C-C0EABD4346BAQ37614037-7A078B40-FD35-46DB-949E-BF02F86EA03EQ38109246-13B1435B-7726-4949-A7F1-7A57A77BBE46Q38293586-97F85651-03C3-4BA4-BAC4-C5F0A786C9BDQ38371073-22EE0CB6-4CC1-4F3F-B6A8-4BD0C25F9D98Q38520018-7044C487-75BD-4619-B767-4915CE8F2228Q38760691-B740C938-6294-41B3-86FD-067E9CD17901Q38853138-F921790D-B0FF-4A8D-9EF5-DB0C4369B22AQ38892529-751BD61B-ABD3-4574-A240-E40A2FBA037CQ38894382-3DED8A6A-98F5-420D-BB76-C4A53EC0CB0EQ39528138-2A850AF0-D134-4C6C-BD47-9B3672D68303Q40069834-9421304E-635C-4A14-997C-9A892DB895FEQ42263367-CA0CAA95-F6C0-48AD-A12F-D437EC59F5FFQ45326057-E92A4A01-EE1D-47C6-B3C3-45CF535407E3Q55017189-FAF2365D-15CB-4CC8-B174-EC3ACCC3183E
P2860
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
@ast
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
@en
type
label
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
@ast
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
@en
prefLabel
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
@ast
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
@en
P1433
P1476
Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?
@en
P2093
Peter Vanlandschoot
P304
P356
10.1016/S1471-4906(03)00026-7
P577
2003-03-01T00:00:00Z